ARS Pharmaceuticals, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:SPRY) | MetaTrader

Tam grafiği aç Full chart

Haberler

Cantor Fitzgerald, ARS Pharmaceuticals için hedef fiyatı yükseltti

ARS Pharmaceuticals, Inc. (SPRY) Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals 1Ç 2026 hisse başı kazanç tahminini kaçırdı

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

ARS Pharmaceuticals kazancı $0,12 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek

ARS Pharmaceuticals hisseleri gelir beklentisini aştı, yüzde 2 yükseldi

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most A

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

ARS Pharmaceuticals, Donn Casale’yi başkan olarak atadı

Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates

Cronos Group (CRON) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates